Therapeutic Cooling Treatment Tested in High-Profile Sports Case
Studies of the impact of therapeutic cooling show reduced long-term brain damage and improved neurological function in sudden cardiac arrest patients. In the last few days, a professional football player and his doctors may have demonstrated similar neurological treatment benefits in association with spinal cord injury. Cincinnati, OH (PRWEB) September 13, 2007 -- Studies of the impact of therapeutic cooling show reduced long-term brain damage and improved neurological function in sudden cardiac arrest patients. In the last few days, a professional football player and his doctors may have demonstrated similar neurological treatment benefits in association with spinal cord injury. Cincinnati Sub-Zero (CSZ), a developer of advanced patient temperature management systems, including highly effective and efficient cooling products, recently reviewed the results of successive years of cooling therapy studies around the world. "Improved outcomes in out-of-hospital cardiac arrest patients is clear in study after study of therapeutic hypothermia solutions -- and these are human trials that have taken place in the US, Canada, Norway, Sweden, and other countries," said Mark Beran, Vice President and General Manager of CSZ Medical. "ILCOR (The International Liaison Committee on Resuscitation) produced the first international guidelines to include therapeutic cooling in 2000. The New England Journal of Medicine first noted hypothermia treatment benefits to cardiac patients in 2002. The American Heart Association published a therapy-supportive advisory statement in 2003, following an international standard-setting review. And, the international community issued additional recommendations in 2005. More and more emergency services providers are adopting the treatment, and it is increasingly clear that the solution timing -- the sooner, the better -- is vital," said Beran. Where therapeutic cooling has been shown to halt brain cell death, it now may very well be illustrating it also can hinder spinal nerve death. In the case of the football player's neurological damage, doctors and experts speculate the hypothermia may have contributed to slowing his body's ability to produce swelling and irritation, reducing the possibility of spinal nerve death. While controversy still exists regarding the exact means of neurological improvement, studies do show that patients receiving controlled cooling therapy are more likely to survive their hospital stay, and be discharged with more neurological function.
The 1st Annual International Therapeutic Temperature Management (TTM Congress) will be held in Cancun, Mexico from December 4-7, 2007. The TTM Congress will convene experts from around the world to review practices and research in therapeutic hypothermia and patient temperature modulation. CSZ Medical is an unrestricted educational grant sponsor for the event. More information is available at TTMCongress.com. About Cincinnati Sub-Zero and Cincinnati Sub-Zero, Medical Division:
The parent of three separate divisions, Cincinnati Sub-Zero (CSZ) is a leading manufacturer and provider of temperature management products for medical and industrial needs. CSZ is the customer-focused manufacturer of multiple therapeutic temperature control products for the healthcare market, a complete line of industrial environmental simulation testing chambers and a first-class, on-site testing laboratory. Cincinnati Sub-Zero, Medical Division has delivered patient temperature management systems to healthcare professionals since 1963, always designed with the patient in mind. The complete line of products includes therapeutic heat therapy, cold therapy units along with a complete line of warming blankets and cooling blankets for body temperature regulation and hyper-hypothermia treatment. The Whole Body Cooling System is designed for induced clinical hypothermia and it provides an effective alternative to traditional patient cooling techniques. This revolutionary system combines a Kool Kit® (the CSZ Head Wrap, Patient Vest and custom lower body pad) and the Blanketrol® III Hypo-Hyperthermia system. In addition, CSZ recently introduced the Gelli Roll® to its line of Hyper-hypothermia pads. This unique pad combines temperature management with tissue pressure reduction and will provide unique opportunities for warming and cooling your most challenging patients. CSZ also offers a wide variety of Hypo-Hyperthermia blankets that can be utilized with the Blanketrol® line. These single-patient use or reusable blankets are designed for quick, even-temperature distribution and efficient circulation, which make them the ideal choice for warming and cooling. Please visit CSZ Medical to learn more about CSZ, Medical Division. Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof. Contact:
Robin Piazza
Watermark Research Partners
317.576.1818
www.watermarkrs.com ###
Simillar Articles
|
